Early Enteral Nutrition in Severe Acute Pancreatitis

November 26, 2013 updated by: Erzhen Chen, Ruijin Hospital
to compare different time points for enteral nutrition in SAP patients

Study Overview

Detailed Description

There is increasing evidence that indicates Early Enteral Nutrition(EEN) may be associated with improved outcome in acute pancreatitis patients. However, some SAP patients failed to EEN. The researchers of this study aim to investigate the opportunity of EEN on the clinical outcomes of SAP patients.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: qiang En mao

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China
        • Recruiting
        • Ruijin
        • Contact:
        • Principal Investigator:
          • xu Wen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Diagnosis of pancreatitis: Typical pain increase in serum lipase or amylase
  2. Onset of abdominal pain within <=72h before admission
  3. moderate severe or severe Acute Pancreatitis according to Atlanta criteria revisited in 2012 ffff

    Exclusion Criteria:

    • 1. Pregnancy 2.tumor 3. acute onset of chronic pancreatitis
  4. chronic disease of any organ (heart lung gastrointestinal renal etc.) 5. Pre-existing disease with life expectancy < 3 months 7.receive parenteral nutrition or enteral nutrition before admitting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: early enteral nutrition

Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.

  • The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
  • After catharsis, Standard enteral nutrition liquid regimen (Peptisorb Liquid)will be used step by step.
  • Patients are targeted to receive calories for 25 kcal/kg/day.

Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.

The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.

• After catharsis, Standard enteral nutrition liquid regimen will be used step by step.

Patients are targeted to receive calories for 25 kcal/kg/day.

nutrition form: short peptide ,1 kcal/ml,target 200k kcal/day

Active Comparator: modified early enteral nutrition

Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.

  • The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
  • After catharsis, Only Normal Saline were given through Naso-gastro-Jejunal tube until 2 or more followed requirements were met mean arterial pressure≥65mmHg; oxygenation index≥ 300;APCHEII≤8; intra-abdominal pressure <20mmHg).Then Standard enteral nutrition liquid regimen (Peptisorb Liquid) will be used step by step.
  • Patients are targeted to receive calories for 25 kcal/kg/day.

Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.

  • The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
  • After catharsis, Only Normal Saline were given through nasojejunal tube until 2 or more followed requirements were meted (mean arterial pressure≥65mmHg; oxygenation index≥ 300;APCHEII≤8; intra-abdominal pressure <20mmHg).Then Standard enteral nutrition liquid regimen (Peptisorb Liquid) will be used step by step.
  • Patients are targeted to receive calories for 25 kcal/kg/day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality
Time Frame: 28days
the rate of patients died
28days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
operation rate
Time Frame: 2 months
The rate of patients received operation for pancreatitis debridement
2 months
fulfilling enteral nutrition target(≥25Kcal/kg/day)
Time Frame: 7 days
enteral nutrition target set as ≥25Kcal/kg/day
7 days

Other Outcome Measures

Outcome Measure
Time Frame
inta-abdominal infection
Time Frame: 2 months
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Qiang en Mao, phd, Emergency intensive care unit of Ruijin Hospital
  • Principal Investigator: Wen xu, Master, Doctor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Anticipated)

September 1, 2016

Study Completion (Anticipated)

August 1, 2017

Study Registration Dates

First Submitted

November 5, 2013

First Submitted That Met QC Criteria

November 26, 2013

First Posted (Estimate)

December 4, 2013

Study Record Updates

Last Update Posted (Estimate)

December 4, 2013

Last Update Submitted That Met QC Criteria

November 26, 2013

Last Verified

November 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • RJpancreatitis02 (Other Identifier: RJH)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pancreatitis

Clinical Trials on early enteral nutrition

3
Subscribe